Japan MHLW grants reimbursement approval for Medtronic Symplicity Spyral renal denervation system
Reuters
Feb 19
Japan MHLW grants reimbursement approval for Medtronic Symplicity Spyral renal denervation system
Medtronic plc said Japan’s Ministry of Health, Labour and Welfare has granted reimbursement approval for the company’s Symplicity Spyral renal denervation system for treating resistant hypertension in Japan. The minimally invasive procedure uses a catheter to deliver radiofrequency energy to renal nerves and leaves no implant behind.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medtronic plc published the original content used to generate this news brief on February 19, 2026, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.